• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴结转移与DNA倍体作为乳腺浸润性导管癌的预后因素

Lymph node metastases versus DNA ploidy as prognostic factors for invasive ductal carcinoma of the breast.

作者信息

Noguchi M, Taniya T, Ohta N, Koyasaki N, Miyazaki I, Mizukami Y

机构信息

Operation Center, Kanazawa University Hospital, School of Medicine, Japan.

出版信息

Breast Cancer Res Treat. 1991 Sep;19(1):23-31. doi: 10.1007/BF01975201.

DOI:10.1007/BF01975201
PMID:1661623
Abstract

We evaluated the relationship between the DNA ploidy status and other variable prognostic factors, especially regional lymph node metastases, in 121 patients with invasive ductal carcinoma of breast, together with the value of these factors in estimating the prognostic of breast cancer. The ploidy status was diploid in 40% of the patients, and aneuploid in 60%. A significantly higher incidence of aneuploidy was found in patients with more than 4 positive axillary lymph nodes, positive internal mammary lymph nodes, or clinical stage 3 of malignancy. In a univariate study, overall survival and disease-free survival were significantly correlated with axillary and internal mammary lymph node metastases, tumor size, and clinical stage of malignancy. The disease-free survival rates for the diploid group tended to be somewhat higher than those for the aneuploid group of patients without axillary lymph node metastases. In the multivariate analysis, however, only axillary lymph node metastasis was significantly correlated with overall survival and disease-free survival. There was also a trend for the internal mammary lymph node metastases to be correlated with survival. As the DNA ploidy status was closely correlated with the axillary and internal mammary lymph node metastases, it did not appear to be an independent prognostic factor in this small series.

摘要

我们评估了121例乳腺浸润性导管癌患者的DNA倍体状态与其他可变预后因素之间的关系,尤其是区域淋巴结转移情况,以及这些因素在评估乳腺癌预后方面的价值。40%的患者倍体状态为二倍体,60%为非整倍体。在腋窝淋巴结阳性超过4个、胸骨旁淋巴结阳性或临床恶性分期为3期的患者中,非整倍体的发生率显著更高。在单因素研究中,总生存期和无病生存期与腋窝和胸骨旁淋巴结转移、肿瘤大小以及临床恶性分期显著相关。在无腋窝淋巴结转移的患者中,二倍体组的无病生存率往往略高于非整倍体组。然而,在多因素分析中,只有腋窝淋巴结转移与总生存期和无病生存期显著相关。胸骨旁淋巴结转移与生存率也存在一定的相关性趋势。由于DNA倍体状态与腋窝和胸骨旁淋巴结转移密切相关,在这个小样本系列中,它似乎不是一个独立的预后因素。

相似文献

1
Lymph node metastases versus DNA ploidy as prognostic factors for invasive ductal carcinoma of the breast.淋巴结转移与DNA倍体作为乳腺浸润性导管癌的预后因素
Breast Cancer Res Treat. 1991 Sep;19(1):23-31. doi: 10.1007/BF01975201.
2
Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer.重新评估内乳淋巴结转移作为乳腺癌患者预后因素的情况。
Cancer. 1991 Nov 1;68(9):1918-25. doi: 10.1002/1097-0142(19911101)68:9<1918::aid-cncr2820680913>3.0.co;2-l.
3
The relationship between lymph node metastases and DNA-ploidy status as prognostic factors in invasive breast cancer.在浸润性乳腺癌中,淋巴结转移与DNA倍体状态作为预后因素的关系。
Surg Today. 1992;22(3):213-20. doi: 10.1007/BF00308825.
4
Internal mammary nodal status is a more reliable prognostic factor than DNA ploidy and c-erb B-2 expression in patients with breast cancer.对于乳腺癌患者,内乳淋巴结状态是比DNA倍体和c-erb B-2表达更可靠的预后因素。
Arch Surg. 1993 Feb;128(2):242-6. doi: 10.1001/archsurg.1993.01420140119020.
5
[Prognostic significance of internal mammary lymph node metastases in breast cancer patients].[乳腺癌患者内乳淋巴结转移的预后意义]
Nihon Geka Gakkai Zasshi. 1992 Mar;93(3):295-9.
6
Risk of internal mammary lymph node metastases and its prognostic value in breast cancer patients.乳腺癌患者内乳淋巴结转移风险及其预后价值
J Surg Oncol. 1993 Jan;52(1):26-30. doi: 10.1002/jso.2930520108.
7
DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study.DNA 倍性比淋巴结转移更能作为宫颈癌的预后因素:一项前瞻性研究的 10 年结果。
Int J Gynecol Cancer. 2011 May;21(4):678-84. doi: 10.1097/IGC.0b013e3182126f85.
8
Two-color, cytokeratin-labeled dna flow cytometric analysis of 332 breast cancers: lack of prognostic value with 12-year follow-up.332例乳腺癌的双色细胞角蛋白标记DNA流式细胞术分析:12年随访结果显示其无预后价值
Arch Pathol Lab Med. 2001 Mar;125(3):364-74. doi: 10.5858/2001-125-0364-TCCLDF.
9
Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study.我们能否确定具有最小腋窝淋巴结受累风险的小浸润性(T1a,b)乳腺癌群体?一项组织病理学和 DNA 流式细胞术研究。
Pathol Res Pract. 2011 Jul 15;207(7):438-42. doi: 10.1016/j.prp.2011.04.005. Epub 2011 Jun 20.
10
Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.石蜡包埋浸润性乳腺癌中HER-2/neu蛋白定量表达、DNA倍体以及形态学和临床特征的长期比较预后价值
Lab Invest. 1991 Feb;64(2):215-23.

引用本文的文献

1
Past, Present and Future of Flow Cytometry in Breast Cancer - A Systematic Review.乳腺癌流式细胞术的过去、现在与未来——一项系统综述
EJIFCC. 2019 Nov 25;30(4):423-437. eCollection 2019 Nov.
2
Flow Cytometric Assay of c-erbB-2 Protein in Fine Needle Aspirates of Fresh and Frozen Human Breast Cancer Tissues.新鲜及冷冻人乳腺癌组织细针穿刺物中c-erbB-2蛋白的流式细胞术检测
Breast Cancer. 1996 Jun 28;3(2):111-117. doi: 10.1007/BF02966971.
3
Prognostic significance of cell cycle parameters in infiltrative ductal breast carcinoma.浸润性导管癌中细胞周期参数的预后意义

本文引用的文献

1
A COMPARISON OF SURVIVAL RATES BETWEEN AMERICAN AND JAPANESE PATIENTS WITH BREAST CANCER.美国和日本乳腺癌患者生存率的比较
Surg Gynecol Obstet. 1963 Aug;117:196-200.
2
Management and survival of female breast cancer: results of a national survey by the American College of Surgeons.女性乳腺癌的管理与生存情况:美国外科医师学会全国调查结果
Cancer. 1980 Jun 15;45(12):2917-24. doi: 10.1002/1097-0142(19800615)45:12<2917::aid-cncr2820451203>3.0.co;2-m.
3
The world Health Organization Histological Typing of Breast Tumors--Second Edition. The World Organization.
J Clin Lab Anal. 1998;12(3):131-6. doi: 10.1002/(SICI)1098-2825(1998)12:3&#x0003c;131::AID-JCLA1&#x0003e;3.0.CO;2-C.
4
S-phase fraction identifies high-risk subgroups among DNA-diploid breast cancers.S期分数可识别DNA二倍体乳腺癌中的高危亚组。
Breast Cancer Res Treat. 1996;38(3):265-75. doi: 10.1007/BF01806145.
5
DNA Cytometry Consensus Conference. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast.DNA细胞计量学共识会议。关于DNA细胞计量学在乳腺癌临床应用的共识性综述。
Breast Cancer Res Treat. 1993 Oct;28(1):55-9. doi: 10.1007/BF00666357.
世界卫生组织《乳腺肿瘤组织学分类——第二版》。世界卫生组织。
Am J Clin Pathol. 1982 Dec;78(6):806-16. doi: 10.1093/ajcp/78.6.806.
4
Relationship of steroid receptor, cell kinetics, and clinical status in patients with breast cancer.乳腺癌患者中类固醇受体、细胞动力学与临床状态的关系
Cancer Res. 1981 Sep;41(9 Pt 1):3524-9.
5
Deoxyribonucleic acid (DNA) content of carcinomas and prognosis in human breast cancer.
Int J Cancer. 1983 Dec 15;32(6):693-6. doi: 10.1002/ijc.2910320607.
6
Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.使用流式细胞术分析石蜡包埋病理材料细胞DNA含量的方法。
J Histochem Cytochem. 1983 Nov;31(11):1333-5. doi: 10.1177/31.11.6619538.
7
DNA flow cytometry in primary breast carcinoma.
Acta Pathol Microbiol Immunol Scand A. 1984 Nov;92(6):475-80. doi: 10.1111/j.1699-0463.1984.tb04430.x.
8
Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients.细胞DNA含量对II期乳腺癌患者无病生存期的影响。
Cancer Res. 1984 Nov;44(11):5395-8.
9
Correlation of cell-cycle kinetics, hormone receptors, histopathology, and nodal status in human breast cancer.人类乳腺癌中细胞周期动力学、激素受体、组织病理学与淋巴结状态的相关性
Cancer. 1984 Oct 15;54(8):1586-90. doi: 10.1002/1097-0142(19841015)54:8<1586::aid-cncr2820540820>3.0.co;2-9.
10
Flow-cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations.原发性乳腺癌的流式细胞术DNA分析及其与临床病理的相关性
Cytometry. 1984 Jul;5(4):408-19. doi: 10.1002/cyto.990050419.